Characterisation of a novel group B oncolytic adenovirus, ColoAd1
<p>Developing high potent oncolytic virus with multimodal antitumour capabilities is crucial for realizing the full potential of oncolytic virotherapy in cancer treatment. ColoAd1 is a novel replicating chimeric group B adenovirus recently bioselected from a large library of recombinant virus...
Hlavní autor: | |
---|---|
Další autoři: | |
Médium: | Diplomová práce |
Jazyk: | English |
Vydáno: |
2011
|
Témata: |